Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis
- 1 March 2003
- journal article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 2 (1) , 19-24
- https://doi.org/10.1016/s1569-1993(02)00143-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Oxidant Mechanisms in Gentamicin NephrotoxicityRenal Failure, 1999
- Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinicThe Lancet, 1996
- Fosfomycin trometamolJournal of Antimicrobial Chemotherapy, 1994
- Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 1993
- Pharmacokinetic Comparison between Fosfomycin and Other Phosphonic Acid DerivativesChemotherapy, 1990
- Antimicrobial activity of fosfomycin in vitroJournal of Antimicrobial Chemotherapy, 1983
- Fosfomycin: Absorption and ExcretionChemotherapy, 1977
- Pharmacokinetics of FosfomycinChemotherapy, 1977
- THE MECHANISM OF ACTION OF FOSFOMYCIN (PHOSPHONOMYCIN)Annals of the New York Academy of Sciences, 1974
- Phosphonomycin, a New Antibiotic Produced by Strains of StreptomycesScience, 1969